KOMIPHARM INTERNATIONAL CO., LTD. is a Korea-based company engaged in the development and manufacturing of veterinary vaccines, veterinary pharmaceuticals and natural food additives. The Company produces its products under three categories: vaccines, total vaccine of respiratory disease for swine, vaccine of anthrax disease and black leg for cattle, vaccine for infectious bronchitis and Newcastle disease, and canine respiratory infection killed vaccine; chemical products, including antibiotics, nutrients, disinfectants and others, used to treat pneumonia, pasteurellosis, enteritis, mastitis, swine erysipelas, septicemia, leptospirosis and bacterial diseases for livestock, as well as natural extracts, which are used for foods, cosmetics, pharmaceuticals and others. As of December 31, 2011, the Company had one affiliated company, Komipharm International America, Inc.